BeiGene(BGNE) - 2026 Q1 - Earnings Call Transcript
BeOne Medicines (NasdaqGS:BGNE) Q1 2026 Earnings call May 06, 2026 08:00 AM ET Company ParticipantsAaron Rosenberg - CFOAmit Aggarwal - Chief Medical Officer for HematologyDaniel Maller - Head of Investor RelationsGregory Renza - Managing DirectorJessica Fye - Managing DirectorJohn Oyler - Co-founder, Chairman, and CEOMark Lanasa - Chief Medical Officer for Solid TumorsMatt Shaulis - General Manager of North AmericaReni Benjamin - Managing DirectorSean Laaman - Executive DirectorWang Lai - President and Glo ...